Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5Côme Lepage, Sabine Luttmann, Jean Faivre et al.|European Journal of Cancer|2015Cited by 148
A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)Jaume Capdevila, Alice Durand, Virginia Pubul et al.|BMC Cancer|2025Cited by 7
Deep Learning on Histologic Slides Accurately Predicts Consensus Molecular Subtypes and Spatial Heterogeneity in Colon CancerJean-Eudes Le Douget, Pierre Laurent‐Puig, Paul Jacob et al.|Modern Pathology|2025Cited by 3
Correction: A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)Jaume Capdevila, Alice Durand, Virginia Pubul et al.|BMC Cancer|2026Cited by 0